Clinical Trial Update: Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating the efficacy and tolerability of LAS41004 formulations in a non-occlusive psoriasis plaque test.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LAS41004

Snippet

Sponsor: Almirall, S.A. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED